Global and Region Hospital Injectable Drugs Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.

    Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.

    The report details the trend, potential and market size of Hospital Injectable Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital Injectable Drugsmarket, defines the market attractiveness level of Hospital Injectable Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hospital Injectable Drugs industry, describes the types of Hospital Injectable Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital Injectable Drugs market and the development prospects and opportunities of Hospital Injectable Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital Injectable Drugs market in Chapter 13.

    By Player:

    • Sanofi

    • Merck & Co

    • Novo Nordisk A/S

    • GlaxoSmithKline plc

    • Johnson & Johnson

    • Novartis AG

    • Sciences

    • Baxter International Inc

    • AstraZeneca

    • Gilead

    • Pfizer Inc

    By Type:

    • Cardiology & Metabolic disorders

    • Neurology

    • Oncology

    • Autoimmune

    • Gastroenterology

    • Hematology

    • Pain

    • Infectious diseases

    • Others

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • E-commerce

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hospital Injectable Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hospital Injectable Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hospital Injectable Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hospital Injectable Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hospital Injectable Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Hospital Injectable Drugs Consumption (2017-2022)

    • 7.2 United States Hospital Injectable Drugs Consumption (2017-2022)

    • 7.3 Europe Hospital Injectable Drugs Consumption (2017-2022)

    • 7.4 China Hospital Injectable Drugs Consumption (2017-2022)

    • 7.5 Japan Hospital Injectable Drugs Consumption (2017-2022)

    • 7.6 India Hospital Injectable Drugs Consumption (2017-2022)

    • 7.7 South Korea Hospital Injectable Drugs Consumption (2017-2022)

    8 Region and Country-wise Hospital Injectable Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Hospital Injectable Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Hospital Injectable Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Hospital Injectable Drugs Consumption Forecast (2022-2028)

    • 8.4 China Hospital Injectable Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Hospital Injectable Drugs Consumption Forecast (2022-2028)

    • 8.6 India Hospital Injectable Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Hospital Injectable Drugs Consumption Forecast (2022-2028)

    9 Global Hospital Injectable Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Hospital Injectable Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cardiology & Metabolic disorders Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Neurology Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Autoimmune Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Gastroenterology Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Hematology Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Pain Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Infectious diseases Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hospital Injectable Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global E-commerce Consumption and Growth Rate (2017-2022)

    10 Global Hospital Injectable Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Hospital Injectable Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cardiology & Metabolic disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Neurology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Autoimmune Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Gastroenterology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Hematology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Pain Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Infectious diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hospital Injectable Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global E-commerce Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hospital Injectable Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hospital Injectable Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hospital Injectable Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hospital Injectable Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hospital Injectable Drugs Market Competitive Analysis

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Details

      • 14.1.2 Sanofi Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sanofi Hospital Injectable Drugs Product and Service

    • 14.2 Merck & Co

      • 14.2.1 Merck & Co Company Details

      • 14.2.2 Merck & Co Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co Hospital Injectable Drugs Product and Service

    • 14.3 Novo Nordisk A/S

      • 14.3.1 Novo Nordisk A/S Company Details

      • 14.3.2 Novo Nordisk A/S Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novo Nordisk A/S Hospital Injectable Drugs Product and Service

    • 14.4 GlaxoSmithKline plc

      • 14.4.1 GlaxoSmithKline plc Company Details

      • 14.4.2 GlaxoSmithKline plc Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline plc Hospital Injectable Drugs Product and Service

    • 14.5 Johnson & Johnson

      • 14.5.1 Johnson & Johnson Company Details

      • 14.5.2 Johnson & Johnson Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Johnson & Johnson Hospital Injectable Drugs Product and Service

    • 14.6 Novartis AG

      • 14.6.1 Novartis AG Company Details

      • 14.6.2 Novartis AG Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novartis AG Hospital Injectable Drugs Product and Service

    • 14.7 Sciences

      • 14.7.1 Sciences Company Details

      • 14.7.2 Sciences Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sciences Hospital Injectable Drugs Product and Service

    • 14.8 Baxter International Inc

      • 14.8.1 Baxter International Inc Company Details

      • 14.8.2 Baxter International Inc Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Baxter International Inc Hospital Injectable Drugs Product and Service

    • 14.9 AstraZeneca

      • 14.9.1 AstraZeneca Company Details

      • 14.9.2 AstraZeneca Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AstraZeneca Hospital Injectable Drugs Product and Service

    • 14.10 Gilead

      • 14.10.1 Gilead Company Details

      • 14.10.2 Gilead Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Gilead Hospital Injectable Drugs Product and Service

    • 14.11 Pfizer Inc

      • 14.11.1 Pfizer Inc Company Details

      • 14.11.2 Pfizer Inc Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Inc Hospital Injectable Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hospital Injectable Drugs

    • Figure Hospital Injectable Drugs Picture

    • Table Global Hospital Injectable Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital Injectable Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital Injectable Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hospital Injectable Drugs Consumption by Country (2017-2022)

    • Figure United States Hospital Injectable Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Hospital Injectable Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Hospital Injectable Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Hospital Injectable Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Hospital Injectable Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hospital Injectable Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Injectable Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Hospital Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hospital Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hospital Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hospital Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hospital Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hospital Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology & Metabolic disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Neurology Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Consumption and Growth Rate (2017-2022)

    • Figure Global Gastroenterology Consumption and Growth Rate (2017-2022)

    • Figure Global Hematology Consumption and Growth Rate (2017-2022)

    • Figure Global Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global E-commerce Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology & Metabolic disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastroenterology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hematology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global E-commerce Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hospital Injectable Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hospital Injectable Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Hospital Injectable Drugs Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Hospital Injectable Drugs Product and Service

    • Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk A/S Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S Hospital Injectable Drugs Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Hospital Injectable Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Hospital Injectable Drugs Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Hospital Injectable Drugs Product and Service

    • Table Sciences (Foundation Year, Company Profile and etc.)

    • Table Sciences Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sciences Hospital Injectable Drugs Product and Service

    • Table Baxter International Inc (Foundation Year, Company Profile and etc.)

    • Table Baxter International Inc Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Inc Hospital Injectable Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Hospital Injectable Drugs Product and Service

    • Table Gilead (Foundation Year, Company Profile and etc.)

    • Table Gilead Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Hospital Injectable Drugs Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Hospital Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Hospital Injectable Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.